🇺🇸 FDA
Pipeline program

Peramivir 150mg

BCX1812-312

Phase 3 small_molecule terminated

Quick answer

Peramivir 150mg for Influenza is a Phase 3 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOCRYST PHARMACEUTICALS INC
Indication
Influenza
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials